| Similar Articles |
|---|
 |
AFP eWire
January 31, 2005 |
Next Big Fundraising Trend: Giving Through Your Cell Phone Donors will soon be able to make charitable gifts by using their cell phones to send text messages.   |
Entrepreneur
November 2007
Chris Penttila |
Getting Feedback From Peers Getting regular, one-on-one feedback from another entrepreneur in a similar industry or stage of growth can reap enormous rewards for your business. |
The Motley Fool
September 14, 2009
Brian Orelli |
The Clock Is Ticking for Elan Elan is getting closer to the Sept. 26 deadline to fix its contract with Johnson & Johnson. If it doesn't, Biogen Idec has the right to take full control of Elan's and Biogen's multiple-sclerosis drug, Tysabri. |
Inc.
April 2004
Alison Stein Wellner |
Case Study Colin Johnson had a bold plan to transform his consulting firm. But when things went awry, sticking to his guns meant risking everything. |
| AskMen.com |
The Texting Age About two-thirds of all teens use text messaging, mostly due to its simplicity as well as the privacy of being able to communicate without being overheard. |
The Motley Fool
May 28, 2010
Brian Orelli |
How Much Is This Going to Cost J&J? Investors need an answer from Johnson & Johnson about low-quality drugs that were recalled. Is the problem systemic, and if so, how much will it cost the company to fix the problem? |
CRM
July 16, 2015 |
CallFire Partners with Smart Advocate to Provide Text Messaging to Lawyers The integration allows lawyers to text clients with case updates. |
The Motley Fool
May 26, 2010
Brian Orelli |
Is Johnson & Johnson a Buy? Let's see what it says to Congress first on safety issues. |
The Motley Fool
October 17, 2006
Brian Lawler |
See Johnson & Johnson Crawl Earnings growth isn't moving right along because the company has become so big. Investors, take note. |
The Motley Fool
August 27, 2010
Brian Orelli |
A Recall a Week, That's All We Ask For Johnson & Johnson, apparently that's too much. |
IEEE Spectrum
May 2006
Lauren Aaronson |
Parallel Processor How IBM engineer Sandra Johnson contributes to her field, her business, and the community. |
InternetNews
October 10, 2008
Judy Mottl |
Verizon Mulls Text Fee to Milk a Cash Cow While text messaging is booming, Verizon considers increased prices for bulk delivery. Will it send commercial customers running? |
Entrepreneur
September 2004
Rieva Lesonsky |
Keep Your Cool What really counts in sudden situations is how you and your employees handle the problem. |
The Motley Fool
September 15, 2009
Brian Orelli |
What's $115 Million Between Friends? Elan has to fix the mess it had gotten itself into with its multiple sclerosis drug Tysabri. |
CRM
January 10, 2014
Meredith Flynn-Ripley |
Texting, UC, and More: The Future of Business Communication Trends and predictions for 2014. |
The Motley Fool
September 30, 2009
Brian Orelli |
Boston Scientific Pays Up And Johnson & Johnson reaps the rewards. |
PC Magazine
November 28, 2007
Alison Lapp |
Texting for a Cause Issue-oriented text messaging is on the rise. |
The Motley Fool
June 28, 2011
Eric Bleeker |
Johnson & Johnson Is Looking Abroad for Growth Where's Johnson & Johnson generating its sales? |
Fast Company
Stephanie Vozza |
Is It Time To Dramatically Quit Your Day Job? How do you know if you should quit your day job? It depends on your threshold to pain, says Kevin Johnson, author of The Entrepreneur Mind: 100 Essential Beliefs, Characteristics, and Habits of Elite Entrepreneurs. |
The Motley Fool
January 18, 2012 |
What Johnson & Johnson Does With Its Cash Over the last five years, Johnson & Johnson shares returned 14%, which drops to -3% without dividends -- not a bad boost to top off otherwise lowly share performance. |
The Motley Fool
July 12, 2011
Todd Wenning |
What Does Johnson & Johnson Do With Its Free Cash? Johnson & Johnson appears to be making fair use of its free cash flow, and its well-covered dividend may be attractive to income-focused investors. |
The Motley Fool
November 26, 2010
Brian Orelli |
Get It Together, Johnson & Johnson Another day, another recall. |
Entrepreneur
January 2010
Jennifer Wang |
Entrepreneur Magazine's Entrepreneur of 2009 Award Winners The votes are in -- now it's time to meet the top Entrepreneurs and learn their secrets to success. |
The Motley Fool
October 12, 2004
Alyce Lomax |
Take It Away, J&J Should investors sweat a coming slowdown in growth for pharmaceutical and consumer products giant Johnson & Johnson? |
The Motley Fool
July 14, 2008
Brian Orelli |
Foolish Forecast: J&J Trudges Along In advance of earnings analysts wonder if Johnson & Johnson is a recovery story waiting to happen, or still stuck in a rut? |
The Motley Fool
September 14, 2007
Brian Orelli |
J&J's Expensive RNA Purchase Johnson & Johnson sets up a collaboration with Isis Pharmaceuticals to develop compounds to treat diabetes. Investors take note. |
CRM
April 2015
Leonard Klie |
Text Takes Precedence as a Customer Service Preference A new generation of consumers prefers short message service to other ways to reach agents. |
The Motley Fool
July 31, 2007
Nathan Parmelee |
Break Out the Band-Aids at J&J Johnson & Johnson is making some deep cuts to change its cost structure. Shareholders haven't had much to cheer about lately here, but the potential benefits from this move could help cure some of the current softness in the business. |
CRM
December 5, 2011
Judith Aquino |
Leads360 Introduces New Automated Text Message Capabilities Leads360 added automated text messaging to its offerings, allowing sales associates to automate the process of composing and sending text messages via the SPAM-compliant Short Message Service protocol. |
The Motley Fool
April 29, 2011
David Williamson |
Johnson & Johnson's Traumatic Purchase Johnson & Johnson agrees to purchase trauma and spine specialist Synthes. |
The Motley Fool
November 17, 2006
Brian Lawler |
Johnson & Johnson's Good Deal If Conor's stent design can alleviate some of the perceived safety worries about stents, then sales from the Cordis division should spring back up, again making it drive revenue growth for Johnson & Johnson, as it did before this year. Investors, take note. |
InternetNews
November 22, 2004
Tim Gray |
Tegic Gets Smarter With Text Messaging Tegic Communications' latest smart text messaging system includes support for up to 45 languages. |
The Motley Fool
June 4, 2010
Brian Orelli |
Out With Drugs, in With Medical Devices Johnson & Johnson's movement in medical devices and diagnostics is headed in the right direction, but whether Johnson & Johnson is a buy depends a lot on how it handles its current drug problem. Unfortunately investors can't have one without the other. |
The Motley Fool
December 1, 2010
Brian Orelli |
We're Still Buying. Probably. Despite manufacturing problems, Johnson &Johnson continues with its purchase of Crucell. |
The Motley Fool
October 19, 2011
Brian Orelli |
Not the Best Quarter, but... There's little reason to worry about Johnson & Johnson. |
The Motley Fool
August 14, 2007
Brian Orelli |
A No-Win Situation Johnson & Johnson is suing the beloved American Red Cross for trademark infringement. Johnson & Johnson just needs to walk a fine line between having its brand eroded by the Red Cross and having its brand eroded by a public relations nightmare. |
The Motley Fool
October 19, 2010
Brian Orelli |
Watch a 40% Decline Disappear The greatest thing going for Johnson & Johnson is its diversity in product offerings. |
The Motley Fool
December 31, 2009
Brian Orelli |
The FDA (Still) Hates Antibiotic Makers Johnson & Johnson and Basilea are the agency's latest victims. |
The Motley Fool
April 21, 2010
Brian Orelli |
Yawn! Get Back to Me Next Quarter, J&J There's more stagnant growth from the health-care giant. |
The Motley Fool
February 22, 2010
Brian Orelli |
So Long, See You in Arbitration After another rejection, Johnson & Johnson and Basilea call it quits. |
The Motley Fool
July 12, 2010
Brian Orelli |
Johnson & Johnson MENDs a Hole Another neurovascular device maker, Micrus Endovascular, gets snatched up. |
The Motley Fool
June 25, 2010
Brian Orelli |
The Joys of Being Large and Diversified Johnson & Johnson's plant closure is a rounding error. |
Fast Company
November 2015
Max Chafkin |
How Failed JC Penney CEO Ron Johnson Is Redeeming Himself With Enjoy The company sells consumer electronics via the web and has its couriers, or "Experts," in Johnson's parlance, act as modern-day Maytag Men, hand-delivering the items in as little as four hours. |
The Motley Fool
July 19, 2011
Brian Orelli |
J&J: Better, but Not Best A decent-looking quarter, but a turnaround could still take awhile. |
The Motley Fool
January 26, 2010
Brian Orelli |
Is the Best of Johnson & Johnson Behind It? Johnson & Johnson announces that its sales fell for the first time in 76 years. |
The Motley Fool
June 15, 2011
Brian Orelli |
Johnson & Johnson Is a Quitter The diversified health-care giant has decided to exit the drug-eluting stent market. |
The Motley Fool
December 29, 2011
Matt Thalman |
3 Companies That Give Back to Shareholders These three companies have consistently increased the value of each outstanding share: UPS... Johnson & Johnson... ExxonMobil... |
The Motley Fool
February 28, 2011
Brian Orelli |
Johnson & Johnson Parties Like It's 1982 The big pharma announced that it was recalling 667,632 packages of Sudafed tablets because the instructions contained a typo. |
The Motley Fool
January 23, 2008
Brian Orelli |
A Dose of Stability From J&J Top-line growth looked great at Johnson & Johnson -- more than 16% year over year -- but when you dove a little further into the earnings, growth wasn't quite that stellar. |
Bank Technology News
September 2008
John Adams |
Text, Set, Match As part of a promotion for its burgeoning mobile banking service, Chase gave away thousands of tickets to this year's US Open tennis tournament in New York City via a campaign that used mobile technology as a vital component. |
